Skip to main content
. 2022 Mar 8;41:87. doi: 10.1186/s13046-022-02305-5

Fig. 2.

Fig. 2

HDAC2 knockdown inhibited tumorigenesis in GBM mouse model by inhibiting miR-3189-mediated GLUT3 expression. A Heatmap of RNA sequence analysis in DOX-inducible shHDAC2 GBM cells w/wo doxycycline (n = 3). B Heatmap of miRNA expression in DOX-inducible shHDAC2 GBM cells w/wo doxycycline (n = 3). C miR-3189 binding site of GLUT3 sequences. D Measurement of GLUT3 mRNA expression by qPCR. E IHC of human GBM tissue samples (TMA) for HDAC2 and GLUT3. Quantification of protein levels of HDAC2 and GLUT3. GBM TMA including human brain normal, grade 1, 2, 3, and 4 were classified using IHC. Scale bar: 50 μm. F IHC of human GBM tissue samples (TMA) for Bax and Apaf-1. Scale bar: 50 μm. G Schematic outline of in vivo experimental procedure. H Survival rate of orthotopic GBM mouse models by DOX-inducible shHDAC2 U87MG cells w/wo doxycycline. Tumorigenesis in orthotopic GBM mouse models. Brain sections of mice were stained with H&E. J CT imaging in orthotopic GBM mouse models. K PET imaging in orthotopic GBM mouse models. Graphic representation of SUV image analysis (mean area) rate of each group. L IHC staining of HDAC2 and Ki67 in mouse GBM tissues. Scale bar: 50 μm. M mRNA expression of HDAC2 and GLUT3 in orthotopic GBM mouse tissues by DOX-inducible shHDAC2 U87MG cells w/wo doxycycline using qPCR. N Expression of miR-544 and miR-3189. Representative images of human GBM and mice GBM tissue. Scale bars: 50 μm. All data are expressed as the mean ± SD from three independent experiments, each performed in triplicate. *p < 0.05, **p < 0.01, ***p < 0.001